A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
55
Participants
Timeline
Start Date
November 30, 2012
Primary Completion Date
March 31, 2013
Study Completion Date
March 31, 2013
Conditions
Healthy SubjectsCastration Resistant Prostate Cancer (CRPC)Relative BioavailabilityMDV3100